𩺠å
§ç§å°ç§èåç
ð äžé éé»
- 22E: liquid biopsy multi-cancer screening (Galleri), AI mammography, cervical HPV self-sampling
- Taiwan: 4 倧ç篩檢ææ
ð Pearls (10)
- Galleri (cell-free DNA multi-cancer detection) â emerging
- AI augmented mammography â improving sensitivity
- HPV self-sampling â increasing access
- DAA HCV cure â reduced HCC risk
- HBV antiviral therapy â reduced HCC
- NIH ALL OF US longitudinal data
- Lynch syndrome + colonoscopy q1-2y from 20-25
- BRCA + MRI/mammo + risk-reducing salpingo-oophorectomy
- PALB2 / CHEK2 moderate breast risk genes
- Tobacco taxation most effective public health
ð Taiwan
- 4 倧ç篩檢å
è²»
- HPV vaccine åäžå
è²» (2018+)
- HBV 嬰å
ç«èïŒèª 1984ïŒ
- DAA HCV å¥ä¿
- æèžçå¥ä¿è£å©
- åå¥çœ² multi-cancer èšç«
ð å
§å°éé»
- USPSTF + å°ç£åå¥çœ²
- HPV / HBV / HCV vaccine + treatment
- Chemoprevention (tamoxifen, AI)
- High-risk surveillance (BRCA, Lynch)
- 22E new: liquid biopsy, AI
â ïž AI èçš¿ã